Recent Advances in the Development of Hybrid Drugs
Pharmaceutics · 01.07.2024 · 16 (7) · 889
DOI: 10.3390/pharmaceutics16070889 ↗Kurz gefasst
Editorial in der Zeitschrift Pharmaceutics, online erschienen am 01.07.2024. Verfasst von Tânia S Morais. Beteiligte Einrichtung: Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia (FCT), FCT POPH and FSE-European Social Funds.
Abstract (Originalsprache)
In the search for innovative, selective, effective, and safer treatment strategies, hybrid drugs have gained worldwide momentum [...]
Autor:innen und Institutionen
- Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.
- Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.
ORCID-Profile: Tânia S Morais
Förderung
- Fundação para a Ciência e Tecnologia (FCT)
- FCT POPH and FSE-European Social Funds
Zitieren
APA
Morais, T. S. (2024). Recent Advances in the Development of Hybrid Drugs. Pharmaceutics, 16(7), 889. https://doi.org/10.3390/pharmaceutics16070889
Vancouver
Morais TS. Recent Advances in the Development of Hybrid Drugs. Pharmaceutics. 2024;16(7):889. doi:10.3390/pharmaceutics16070889
BibTeX
@article{Morais2024,
author = {Morais, Tânia S},
title = {Recent Advances in the Development of Hybrid Drugs},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {7},
pages = {889},
doi = {10.3390/pharmaceutics16070889}
}
EUVIMED